OccuRx

About:

OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.

Top Investors: Brandon Capital, Uniseed, Brandon BioCatalyst, Medical Research Commercialisation Fund (MRCF), Stoic VC

Description:

OccuRx, a Melbourne-based biopharmaceutical company, was established in 2014 with venture funding from the Medical Research Commercialisation Fund, Brandon Capital Partners and Uniseed. The Company’s primary focus is on the development of innovative therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis.

Total Funding Amount:

$21.2M

Headquarters Location:

Melbourne, Victoria, Australia

Founded Date:

2014-01-01

Contact Email:

info(AT)occurx.com

Founders:

Darren Kelly

Number of Employees:

1-10

Last Funding Date:

2022-09-09

IPO Status:

Private

Industries: